Similarly, numerous studies have reported high levels of ACE2 in the lower respiratory tract; higher levels of ACE2 expression, such as those seen in smokers and patients with chronic obstructive pulmonary disease (COPD), are associated with higher COVID-19 predisposition and enhanced disease severity [13]. The gene discussed is ACE2; the disease is chronic obstructive pulmonary disease.